The House Energy and Commerce Committee Wednesday approved the reauthorization of the Animal Drug User Fee Act, legislation that allows the Food and Drug Administration to collect fees for certain animal drug applications.
The measure was first approved by the Subcommittee on Health May 8. It was approved the same day by unanimous consent in the Senate.
The National Cattlemen's Beef Association, supporter of the legislation, says it allows pharmaceutical companies to pay a user fee to FDA, which is used to hire additional technical staff. By hiring additional technical staff, FDA is able to approve future animal health products without adding to the burden on taxpayers.
"Cattlemen and women rely on new and innovative animal health products, and for that reason the reauthorization of ADUFA has been one of the NCBA's key priorities this year. I am pleased to see the House Energy and Commerce Committee pass ADUFA reauthorization by a voice vote and look for the full House to consider reauthorization shortly," NCBA President J.D. Alexander said in a statement Thursday.
Additionally, the FDA says the legislation ensures that new animal drug products are safe and effective for animals as well as for the public with respect to animals intended for food consumption.
NCBA representative Dr. Mike Apley, DVM, spoke at the House Energy and Commerce committee hearing in April in support of the legislation.
The reauthorization of ADUFA will generate $98 million in user fees during FY09-FY13, the FDA says. The bill was first passed in 2003 and reauthorized in 2008. It expires this year.